SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-010998
Filing Date
2024-03-22
Accepted
2024-03-22 16:39:33
Documents
17
Period of Report
2024-03-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53071
2 ex99-1.htm EX-99.1 16581
3 ex99-2.htm EX-99.2 6122
4 ex99-1_001.jpg GRAPHIC 4983
5 ex99-2_001.jpg GRAPHIC 4147
  Complete submission text file 0001493152-24-010998.txt   263857

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nphc-20240319.xsd EX-101.SCH 3024
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nphc-20240319_lab.xml EX-101.LAB 34240
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nphc-20240319_pre.xml EX-101.PRE 22365
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3176
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

IRS No.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32141 | Film No.: 24775829
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)